Arcus Capital Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,500
Closed -$45K 102
2019
Q3
$45K Hold
2,500
0.02% 98
2019
Q2
$41K Hold
2,500
0.01% 103
2019
Q1
$45K Buy
+2,500
New +$45K 0.02% 101